Zobrazeno 1 - 6
of 6
pro vyhledávání: '"David T. Chung"'
Autor:
Nazim Kourdougli, Anand Suresh, Benjamin Liu, Pablo Juarez, Ashley Lin, David T. Chung, Anette Graven Sams, Michael Gandal, Verónica Martínez-Cerdeño, Dean V. Buonomano, Benjamin J. Hall, Cédric Mombereau, Carlos Portera-Cailliau
SUMMARYChanges in the function of inhibitory interneurons (INs) during cortical development could contribute to the pathophysiology of neurodevelopmental disorders. Using all-optical in vivo approaches in postnatal mouse somatosensory cortex (S1), we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a49a97dd2a7f48c78eb33fcd2ea43f10
https://doi.org/10.1101/2022.05.17.492368
https://doi.org/10.1101/2022.05.17.492368
Autor:
Ismail Mitha, Andrè J. Bester, Ming-Chu Hsu, Ren-Guang Wu, Dirkie Johanna Van Rensburg, Reury-Perng Perng, Ming-Lin Ho, Joseph Kasumba, Yu-Ting Chang, Chi-Hsin R. King, David T. Chung, Li-Wen Chang
Publikováno v:
Antimicrobial Agents and Chemotherapy. 54:4098-4106
Nemonoxacin, a novel nonfluorinated quinolone, exhibits potent in vitro and in vivo activities against community-acquired pneumonia (CAP) pathogens, including multidrug-resistant Streptococcus pneumoniae . Patients with mild to moderate CAP ( n = 265
Autor:
David T. Chung, Cheng-Yuan Tsai, Ching-Hung Hsu, Barbara Kuzmak, Luke Lin, Li-Wen Chang, Funmi Ajayi, Robert A. Lyon, William S. Aronstein
Publikováno v:
Antimicrobial Agents and Chemotherapy. 54:405-410
Nemonoxacin (TG-873870) is a novel nonfluorinated quinolone with potent broad-spectrum activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus , penicillin- and quinolone-resistant Streptococc
Autor:
Chun-Jung Chen, Kien Thiam Tan, Yen-Jung Lu, Shu-Jen Chen, Hua-Chien Chen, Ren-Shiang Jhou, Yi-Ting Yang, Chien-Hung Chen, David T. Chung
Publikováno v:
Journal of Clinical Oncology. 35:e20522-e20522
e20522 Background: Lung cancer boasts an arsenal of targeted therapies directed at various molecular aberrations such as EGFR mutations and fusion genes. Simultaneous assessment for genetic alterations provides biomarkers to assist clinicians in thei
Autor:
Chi-Hsin R. King, Ming-Chu Hsu, Ching-Hung Hsu, Hao-Chen Tan, Kit-Mui Chiu, Yu-Ting Chang, Cheng-Yuan Tsai, David T. Chung, Shu-Jen Chen, Li-Wen Chang
Publikováno v:
Antimicrobial agents and chemotherapy. 54(1)
Nemonoxacin (TG-873870) is a novel nonfluorinated quinolone with broad-spectrum activities against Gram-positive and Gram-negative aerobic, anaerobic, and atypical pathogens, as well as against methicillin-resistant Staphylococcus aureus , vancomycin
Autor:
Yi Chin Lu, Chi-Hsin R. King, Cheng-Yuan Tsai, Ying-Huey Huang, Ching-Hung Hsu, David T. Chung, Ming-Chu Hsu, Judy H. Yuan, Li-Wen Chang, Yu-Mai Chen, Chi-Feng Yen
Publikováno v:
Blood. 114:866-866
Abstract 866 Background: Stem cells are retained in the bone marrow via the trophic effects of the binding of chemokine stromal cell-derived factor-1α (SDF-1α) to its receptor, CXC chemokine receptor 4 (CXCR4). TG-0054 inhibits SDF-1α/CXCR4 bindin